HINJ Board of Trustees and Associate Members
HINJ BOARD OF TRUSTEES OFFICERS
Jeffrey S. Sherman – Chair
Executive Vice President and General Counsel
Yin C. Becker – Vice Chair
Vice President, Communications and Public Affairs
Mark J. Alles – Vice Chair
Chief Executive Officer
Craig B. Bleifer – Treasurer and Immediate Past Chair
Senior Vice President, General Counsel and Secretary
Daiichi Sankyo, Inc.
Lisa M. Goldman – Board Secretary
Chief Communications Officer
Steven Immergut, M.P.H.
Vice President & Head of Communications and Advocacy Relations, Pharmaceutical
C. R. Bard, Inc.
Timothy M. Ring
Chairman and Chief Executive Officer
Johnson & Johnson
Donald W. Bohn
Vice President, U.S. Government Affairs
Executive Vice President and President, Hospital Therapies
Merck & Co., Inc.
Terri J. Lee
Vice President, Government Affairs and Policy
Novartis Pharmaceuticals Corporation
Daniel P. Casserly
U.S. Country Head
Government Affairs, Novartis Services, Inc.
Novo Nordisk, Inc.
Senior Director, Value Communication & Contract Strategy
BioPharm Franchise & Trade
Market Access Strategy & Innovation
HINJ ASSOCIATE MEMBER REPRESENTATIVES
Abbott Point of Care, Inc.
Amicus Therapeutics, Inc.
Jayne C. Gershkowit
Chief Patient Advocate
Eli Lilly and Company
Timothy P. Lyden
Director, State Government Affairs
Emisphere Technologies, Inc.
Alan L. Rubino
Chief Executive Officer and President
Cynthia L. Sullivan
President and Chief Executive Officer